Pneumonia Vaccine Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0089947
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare pneumonia vaccine market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:7.5
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 7.5
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

INTRODUCTION TO THE MARKET

The Global Pneumonia Vaccine Market is experiencing stable growth due to the surge in demand for its available product range. This demand is sourced in the (end-user industries), many of which are working on developing innovative solutions for the future. The Pneumonia Vaccine market has undergone a gradual integration in the leading business sectors, primarily due to the technological development observed in the industry. Our team of expert analysts has devised this market report by reviewing information collected through both primary and secondary research methodologies.

The Global Pneumonia Vaccine Market size is expected To Be More Than USD 10 by 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026. The report provides a clear insight into current and future developments of the United States pneumonia vaccines market. The report explores a detailed analysis of the top 5 vaccines market assessment in the United States from 2016 to 2019 and forecasts to 2026. The report also details the latest information about the pneumonia vaccines' pricing trends and analysis. Moreover, the report offers insight into the clinical trials and the latest happenings in the pneumonia vaccines market. It also covers reimbursement patterns and offers a clear view of the regulatory landscape.

MARKET SCENARIO

The Pneumonia Vaccine market is consolidated by industry leaders but has been witnessing the entry of newer players in the past few years. The increasing scope of research and development has also widened the range of products and services offered in the sector. The escalating levels of disposable incomes and rising urbanization have concomitantly increased the purchasing power of customers, leading to the growth of the global market. However, stringency in government regulations and policies has made it challenging for newer companies to enter the market.

MARKET SCOPE

The research report studies vital market aspects, underlining the product types, applications, end-user industries, leading geographic regions, top players, and the concentration of the market. The scope of the study extends to these essential factors to give the reader the current market scenario that highlights the areas that are vital from the perspective of investment and the overall growth. The study also examines recent technological advancements and product launches and explains their impact on the growth of the global industry.

LEADING PLAYERS

The report gives an in-depth assessment of the top companies functioning in the global sector and controlling a sizable portion of the overall market. This section also breaks down the expansion tactics adopted by these companies, along with a detailed assessment of their strategic initiatives by highlighting recent deals, mergers & acquisitions, joint ventures, collaborations, product launches, and technological upgradation. The report creates elaborate company profiles of all leading companies to provide the readers with all relevant data on the competitive landscape,  enabling them to capitalize on existing and emerging growth prospects by taking well-informed decisions.

  • Merck
  • Pfizer
  • GlaxoSmithKline (GSK)
  • LG Chem
  • SK Chemical (Sanofi Pasteur)

MARKET SEGMENTATION

The Pneumonia Vaccine market has been segmented on the basis of product types, applications, end-user industries, and leading regional markets. The report segregates the global market for better coverage into regions that account for a major portion of the market share. The leading geographies included in the study are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. This analysis of the different segments and sub-segments is intended to help the reader get a better understanding of the factors contributing to the growth of the worldwide market.

The Following 5 Leading Pneumonia Vaccines Are Detailed with Market Size and Six-Years Forecast

  • Prevnar / Prevnar 13
  • Pneumovax 23
  • V114
  • PF-06482077
  • GSK3

REGIONAL FRAMEWORK

A study of the leading regional markets is crucial for assessing the global presence of the Pneumonia Vaccine industry. The regions included in the report are further analyzed by looking at the presence of Pneumonia Vaccine in major countries in these regions. The regions included in the geographical coverage are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The leading countries in these regions are also considered to establish their standing and contribution to the overall market share. The North America region is set to deliver a steady growth rate in the forecast years owing to the surge in demand seen from the local consumer base.

If you have any special requirement, please let us know and we can provide you the report as your requirement.

1. Executive Summary

2. United States Pneumonia Vaccines Market Size & Analysis (2015 – 2026)

3. United States Pneumonia Vaccines Market Assessment & Opportunity (Value), 2015 – 2026
3.1 Prevnar / Prevnar 13
3.2 Pneumovax 23
3.3 V114
3.4 PF-06482077
3.5 GSK3

4. Key Drivers and Inhibitors of the United States Pneumonia Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pneumonia Vaccines Pricing Trends & Analysis

6. United States Pneumonia Vaccines Reimbursement Policies

7. United States Pneumonia Vaccines Regulatory System

8. Promising Pneumonia Vaccines in the Clinical Development

9. Pneumonia Vaccines Clinical Trials Insight by Phase, Company & Country

10. Latest Happenings in the Pneumonia Vaccines Market

11. Major Deals in the Pneumonia Vaccines Market
11.1 Collaboration Deals
11.2 Licensing Agreement
11.3 Partnership Deals

12. Key Companies Analysis
12.1 Merck
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 Pfizer
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development

List of Tables:

Table 5–1: United States Pneumonia Adult Vaccines Price, 2019 – 2020
Table 5–2: United States Pneumonia Pediatric Vaccines Price, 2019 – 2020
Table 7–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 10–1: Collaboration Deals in the Pneumonia Vaccines Market
Table 10–2: Licensing Agreement in the Pneumonia Vaccines Market
Table 10–3: Partnership Deals in the Pneumonia Vaccines Market

List of Figures:

Figure 2–1: United States Pneumonia Vaccines Market Size (Million US$),2015 – 2019
Figure 2–2: United States Pneumonia Vaccines Market Size Forecast (Million US$),2020 – 2026
Figure 3–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2019
Figure 3–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2020 – 2026
Figure 3–3: United States Pneumovax 23 Market Value (Million US$),2015 – 2019
Figure 3–4: United States Pneumovax 23 Market Value Forecast (Million US$),2020 – 2026
Figure 3–5: United States V114 Market Value (Million US$),2022 – 2026
Figure 3–6: United States PF-06482077 Market Value (Million US$),2022 – 2026
Figure 3–7: United States GSK3 Market Value (Million US$),2024 – 2026

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"